FDA Approves Eli Lilly’s Drug For Advanced Breast Cancer

All NewsSeptember 26, 2025

Eli Lilly secured FDA approval for breast cancer drug Inluriyo and EU clearance for Alzheimer’s therapy Kisunla following strong Phase 3 data.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent